Longevity biotech investments surged to $7.33 billion in 2024, more than doubling from the previous year.
The global anti-aging/longevity sector is projected to expand from $76.36 billion in 2024 to $366.58 billion by 2032.
We bridge the gap between biotech innovation & investment, driving life-extending breakthroughs for future generations.